Put Options

9 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $193 Million - $240 Million
249,500 Added 20.93%
1,441,700 $1.28 Billion
Q2 2024

Aug 14, 2024

SELL
$724.87 - $909.04 $174 Million - $218 Million
-240,000 Reduced 16.76%
1,192,200 $1.08 Billion
Q1 2024

May 15, 2024

SELL
$592.2 - $792.28 $96.2 Million - $129 Million
-162,500 Reduced 10.19%
1,432,200 $1.11 Billion
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $124 Million - $146 Million
235,300 Added 17.31%
1,594,700 $930 Million
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $19.5 Million - $26.9 Million
44,900 Added 3.42%
1,359,400 $730 Million
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $196 Million - $262 Million
557,600 Added 73.67%
1,314,500 $616 Million
Q1 2023

May 15, 2023

SELL
$310.63 - $364.82 $191 Million - $224 Million
-614,800 Reduced 44.82%
756,900 $260 Million
Q4 2022

Feb 14, 2023

SELL
$321.55 - $374.67 $357 Million - $416 Million
-1,110,100 Reduced 44.73%
1,371,700 $502 Million
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $483 Million - $550 Million
1,629,100 Added 191.05%
2,481,800 $802 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $709B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.